# FDA recall D-1528-2016

> **Pfizer Inc.** · Class III · drug recall initiated 2016-09-15.

## Product

PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1528-2016
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-09-15
- **Report date:** 2016-10-05
- **Termination date:** 2017-08-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1528-2016

## Citation

> AI Analytics. FDA recall D-1528-2016. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-1528-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*